A Phase 1, Multi-Cohort, Open-Label, Randomized Pilot Study to Evaluate the Effect of Food and a Proton-Pump Inhibitor (esomeprazole) on the Single-Dose Pharmacokinetics of ARV-102 in Healthy Participants
Latest Information Update: 03 Dec 2025
At a glance
- Drugs ARV 102 (Primary) ; Esomeprazole
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Arvinas
Most Recent Events
- 03 Dec 2025 New trial record